keyboard_arrow_upR4.5 million injection for Rooibos research
keyboard_arrow_downR4.5 million injection for Rooibos research

The SA Rooibos Council (SARC) is ramping up research efforts to better understand exactly how indigenous Rooibos tea could help tackle some of the most prevalent diseases of our time.

keyboard_arrow_upRCSI researchers develop new tuberculosis treatment
keyboard_arrow_downRCSI researchers develop new tuberculosis treatment

Led by researchers at RCSI (Royal College of Surgeons in Ireland), a team of researchers has developed a new treatment for tuberculosis (TB). This work could offer a practical treatment that has the potential to be scaled-up and mass-produced for clinical testing.

keyboard_arrow_upMaking liposomal formulations for the delivery of RNA vaccines
keyboard_arrow_downMaking liposomal formulations for the delivery of RNA vaccines

A Dolomite Microfluidics’ set-up for high throughput single cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia. Anna Blakney, post-doctoral research fellow, explains: ‘Our focus is on vaccine delivery, in particular liposomal formulations […]

keyboard_arrow_upColab seeks to validate a non-animal test for regulatory submission
keyboard_arrow_downColab seeks to validate a non-animal test for regulatory submission

The Institute for In Vitro Sciences (IIVS), which has an established track record in the validation of alternatives to animal testing, teamed up with BASF and Givaudan. The collaboration focused on validating an improved skin sensitisation reactivity method to address the needs of toxicologists and regulators.

keyboard_arrow_upBlockchain to combat type 2 diabetes epidemic in India
keyboard_arrow_downBlockchain to combat type 2 diabetes epidemic in India

A pioneering diabetes pilot to collect, sequence and analyse DNA in India, with the aim of using the data for improved diagnosis and treatment of a disease that is devastating the country.

keyboard_arrow_upSurvey sheds light on weird allergies
keyboard_arrow_downSurvey sheds light on weird allergies

It’s hayfever season – the time of year when nature releases gazillions of microscopic pollen spores into the atmosphere, but while springtime has a whopping 17 million (30 percent) of South Africans in a frenzy, our nation also seems to grapple with much rarer allergies.

keyboard_arrow_upIIVS collaborates with BASF and Givaudan to validate a non-animal test for regulatory submissions
keyboard_arrow_downIIVS collaborates with BASF and Givaudan to validate a non-animal test for regulatory submissions

The Institute for In Vitro Sciences (IIVS), with an established track record in the validation of alternatives to animal testing, is teaming up with BASF and Givaudan to validate an improved skin sensitisation reactivity method to address the needs of toxicologists and regulators.

keyboard_arrow_upLactospore found to reverse depression symptoms
keyboard_arrow_downLactospore found to reverse depression symptoms

A clinical study conducted in India and published in the peer reviewed journal Food & Nutrition Research reported that adults with irritable bowel syndrome (IBS) showed improvement from co-existing depression when they took a probiotic strain Bacillus coagulans MTCC 5856 (2 billion spores per day); subjects of the study given a placebo did not report the same improvement.

keyboard_arrow_upAvon receives patents for groundbreaking rotational infinite effects skin care technology
keyboard_arrow_downAvon receives patents for groundbreaking rotational infinite effects skin care technology

In 2017 Avon introduced ANEW Reversalist Infinite Effects, the world's first rotational anti-aging night cream that provides continuous results that do not stall over a full year*.

keyboard_arrow_upAvailability of orphan medicines varies between European countries
keyboard_arrow_downAvailability of orphan medicines varies between European countries

There are differences in the availability of orphan medicines between different European countries, a new study from the University of Eastern Finland shows.